YY/T 0127.18-2016Biological evaluation of medical devices used in dentistry - Part 18: Dentine barrier cytotoxicity test (English PDF)
口腔医疗器械生物学评价 第18部分:牙本质屏障细胞毒性试验
This is a limited preview
Buy now to download the full PDF (22 pages)
Need quotation for your management?
Get a formal quotation for YY/T 0127.18-2016 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
January 26, 2016
Implementation date
January 1, 2017
Scope
YY/T 0127.18-2016 is the English-translated version of 口腔医疗器械生物学评价 第18部分:牙本质屏障细胞毒性试验.
YY/T 0127.18-2016 is the Chinese pharmaceutical industry standard that gives the dentin barrier cytotoxicity test for dental materials.
It is the eighteenth part of the YY/T 0127 series and sets out the dentin disc that stands for the barrier between a filling and the pulp, the culture of the cells beneath it, the application of the material or of its extract above it, and the measurement of cell viability, so that the effect of the components that can diffuse through dentin is judged as it would be in the tooth. Issued on 26 January 2016, it has applied since 1 January 2017.
Found what you need?
Document preview — YY/T 0127.18-2016
National Standard of the People's Republic of China
- ICS
- 11.060.10
- Classification
- C 33
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword
- 1 Scope
- 2 Normative reference documents
- 3 Purpose
- 4 Appliances and materials
Foreword
YY/T 0127 "oral medical device biological evaluation" is divided into 18 parts.
YY/T 0127.1 Oral material Biological test method Hemolysis test --- YY/T 0127.2 Biological evaluation of oral medical devices Unit 2. Test methods Acute systemic toxicity test. intravenous way;
- YY/T 0127.3 Biological evaluation of oral medical devices - Part 3. Application test in root canals;
- YY/T 0127.4 Biological evaluation of oral medical devices - Unit 2. Test methods - Bone implantation test;
- YY/T 0127.5 Biological evaluation of oral medical devices - Part 5. Inhalation toxicity test;
- YY/T 0127.6 Biology evaluation of oral materials Unit 2. Biological test methods for oral materials - Explicit lethal test;
--- YY/T 0127.7 Biology Evaluation of Oral Materials Unit 2. Biological Test Methods for Dental Materials Dental Implants Application test;
- YY/T 0127.8 Biological evaluation of oral materials Unit 2. Biological test methods for oral materials Subcutaneous implantation test;
- YY/T 0127.9 Biological evaluation of oral medical devices Unit 2. Test methods Cytotoxicity test. Agar diffusion method And membrane diffusion method;
--- YY/T 0127.10 Biological evaluation of oral medical devices Unit 2. Test method Salmonella typhimurium recovery Variable test (Ames test);
- YY/T 0127.11 Biological evaluation of oral medical devices - Part 11. Covering pulp test;
- YY/T 0127.12 Dental Oral Medical Device Biological Evaluation Unit 2. Test Method Micronucleus Test;
- YY/T 0127.13 Biological evaluation of oral medical devices - Unit 2. Test methods - Oral mucosal irritation test;
- YY/T 0127.14 Biological evaluation of oral medical devices - Unit 2. Test methods Acute oral toxicity test;
- YY/T 0127.15 Biological evaluation of oral medical devices Unit 2. Test methods Subacute and subchronic systemic toxicity Test. Oral route;
- YY/T 0127.16 Biological evaluation of oral medical devices Unit 2. Test methods In vitro chromosomes of mammalian cells Distortion test;
- YY/T 0127.17 Biological evaluation of oral medical devices - Part 17. Mutation of mouse lymphoma cells (TK) test;
Oral medical devices - Biological evaluation - Part 18. Dentine barrier - Cytotoxicity test YY/T 0127.18. This section is part 18 of YY/T 0127.
This part is drafted in accordance with the rules given in GB/T 1.1-2009.
This section refers to ISO 7405.:2008 "Evaluation of biocompatibility of dental devices for dental use in dentistry" Appendix B "Dentine barrier fine Cytotoxicity test ".
1 Scope
This part of YY/T 0127 specifies the cytotoxicity test method for dental material dentin barrier.
This part applies to the evaluation of tooth filling materials and dental cavities related to the treatment of materials and filterable components after the dentin barrier to fine The effect of cytotoxicity.
2 Normative reference documents
The following documents are indispensable for the application of this document. For dated references, only the dated edition applies to this document. For undated references, the latest edition (including all modifications) applies to this document.
GB/T 16886.5 Biological evaluation of medical devices - Part 5. In vitro cytotoxicity test (GB/T 16886.5-2003,
ISO 10993-5.:1999, IDT)
GB/T 16886.12 Biological evaluation of medical devices - Part 12. Sample preparation and reference samples (GB/T 16886.12- 2005, ISO 10993-12.:2002)
ISO 7405-AMD..2013 Dentistry-Evaluation ofbiocompatibilityofmedicaldevicesusedinden-tistry (evaluation of biocompatibility of dental instruments for dental use)
3 Purpose
This test was used to evaluate the cytotoxicity of the dental filling material by means of cell culture. Cells and materials are barrier to a dentin Separated, so as to simulate the clinical dental cavity with the repair material filling situation.
If the use of agar or filter filtration method obtained cytotoxicity of 0 to 1, you do not have to carry out the test.
4 Appliances and materials
4.1 Cells
Cells that have established cell lines have been used, for example, from ATCC (AmericanTypeCultureColection) [e.g. ATCCCCL1 (NCTCclone929) mouse fibroblasts] or cells that are selected to clone SV40 large T antigen genes, such as those derived from calf Dental papilla cells. Cells should be maintained in growth medium (37 ± 2) ° C, humidified air containing 5% CO2. Can also be used Other cells that have similar to the nature of the odontoblast or have established cell lines that have physiologically related properties to the pulp tissue.
4.2 Medium
The culture medium should be suitable for the selected cell line, for example provided by ATCC or similar institutions.
Note. See the instructions for HTTP.//WWW.ATCC.ORG. The clonal SV40 large T antigen gene transfected cells were grown in medium containing 20% Fetal heart serum (FBS) MEMalpha, 150 IU/mL penicillin, 150 µg/mL streptomycin, 0.125 µg/mL amphotericin B and 0.1 mg/mL hereditary Mycamycin.
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 22 pages — is available in the English PDF.
Referenced standards
Similar standards
How to Download YY/T 0127.18-2016
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 16886.12-2023 — Biological evaluation of medical devices - Part 12: Sample preparation and reference materials
GB/T 16886.5-2017 — Biological evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity
YY/T 0127.19-2023 — Biological evaluation of medical devices used in dentistry - Part 19: Subacute and subchronic systemic toxicity test: implantation route
Secure payment via Stripe
Payments accepted
YY/T 0127.18-2016
$195.00